QNTM Quantum BioPharma Ltd.
Company Analysis
Latest News
🔴 Quantum BioPharma Ltd. is trading 5.5% down today on profit-taking after yesterday's rally
Quantum BioPharma Ltd. is trading at $3.75 (5.5% down) on profit-taking following a significant upside move in the previous session. • The pullback follows a...
🟢 Quantum BioPharma Ltd. makes sharp 11.2% jump
QNTM is trading at $4.05, up 11.2% versus the comparison close of $3.64 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 Quantum BioPharma Ltd. is trading 6.04% up today amid early-session risk-on sentiment
Quantum BioPharma Ltd. is trading 6.04% up at $3.86 amid a broader market risk-on tone and rotational tape, as no company-specific catalysts have been...
🟢 Quantum BioPharma Ltd. is trading 5.76% up today amid broader market strength
Quantum BioPharma Ltd. is trading at $3.85 (5.76% up) following a strong pre-market bid, though no company-specific catalyst has been identified in recent...
🟢 Quantum BioPharma Ltd. is trading 6% up today amid a broad risk-on rally and U.S.–Iran peace breakthrough
Quantum BioPharma Ltd. is trading 6% up at $4.06 in pre-market, rebounding from recent multi-day weakness and a 4.3% slide on Friday. • The upward move aligns...
🔴 Quantum BioPharma Ltd. is trading 5% down today, extending a multi-day slide on technical weakness
Quantum BioPharma Ltd. is trading at $3.80 (5% down) as the stock continues to face downward pressure despite a lack of fresh fundamental catalysts. • The...
🟢 Quantum BioPharma Ltd. is trading 6% up today with no clear catalyst yet
Quantum BioPharma Ltd. is trading 6% higher at $4.24 in pre-market sessions with no clear primary catalyst identifiable for the move. • The stock is extending...
🟢 Quantum BioPharma Ltd. is trading 7.1% up today as shares rebound from FDA clinical hold selloff
Quantum BioPharma Ltd. is trading 7.1% up at $4.17 as shares stage a relief bounce following a sharp selloff triggered by an FDA clinical hold on its lead drug...
🔴 Quantum BioPharma Ltd. is trading 10.6% down today as FDA clinical hold on Lucid-MS intensifies selling pressure
Quantum BioPharma Ltd. is trading 10.6% down at $3.62 as selling pressure intensifies following an FDA clinical hold on its lead multiple sclerosis candidate,...
🔴 Quantum BioPharma Ltd. is trading 5.2% down today as selling resumes following FDA clinical hold
Quantum BioPharma Ltd. is trading 5.2% down at $3.84 as selling resumes following an FDA clinical hold on its lead multiple sclerosis candidate. • The stock...
🟢 Quantum BioPharma Ltd. is trading 5.4% up today as it rebounds from last week's FDA clinical hold selloff
Quantum BioPharma Ltd. is trading at $4.27 (+5.43%) after hours as the stock rebounds from a sharp decline triggered by a recent regulatory setback. • The...
🟢 Quantum BioPharma Ltd. is trading 5% up today as shares rebound from FDA clinical hold selloff
Quantum BioPharma Ltd. is trading 5% up at $4.47 as shares rebound from last week’s steep slide triggered by an FDA clinical hold on its lead multiple...
🟢 Quantum BioPharma Ltd. is trading 10.3% up today as it rebounds from a multi-session selloff following an FDA clinical hold
Quantum BioPharma Ltd. is trading at $4.70 (up 10.3%) in pre-market, attempting to recover from a sharp multi-session decline triggered by an FDA clinical hold...
🔴 Quantum BioPharma Ltd. is trading 7.1% down today following an FDA clinical hold on its lead MS candidate
Quantum BioPharma Ltd. is trading at $4.16 (7.1% down) today as shares continue to sell off following an FDA clinical hold on the company's lead multiple...
🔴 Quantum BioPharma Ltd. is trading 10.3% down today as FDA clinical hold on lead asset sparks survival concerns
Quantum BioPharma Ltd. is trading 10.3% down at $4.38 as selling continues following a major regulatory setback for its lead multiple sclerosis candidate. •...
Quantum BioPharma's FDA Rejection Torches 36% of Its Value in a Week — Can a Micro-Cap With $9.8 Million in Cash Survive the Setback?
Shares of Quantum BioPharma (NASDAQ: QNTM) cratered to $4.47 Wednesday, extending a brutal slide that has erased more than 36% of the stock's value since May...
🔴 Quantum BioPharma Ltd. is trading 8.3% down today as selling pressure persists following FDA clinical hold on Lucid-MS
Quantum BioPharma Ltd. is trading 8.3% down at $4.47 as selling pressure persists after its lead MS candidate, Lucid-MS, was placed on an FDA clinical hold. •...
🔴 Quantum BioPharma Ltd. is trading 2.2% down today as FDA clinical hold on Lucid-MS IND weighs on shares
Quantum BioPharma Ltd. is trading at $4.77 (2.2% down) today, extending a sharp multi-day slide from above $7.00 as the market continues to digest recent...
🟢 Quantum BioPharma Ltd. is trading 7.0% up today as shares rebound from FDA clinical hold selloff
Quantum BioPharma Ltd. is trading at $5.47 (7.0% up) in pre-market, rebounding modestly after heavy selling linked to a recent FDA clinical hold. • The stock...
🔴 Quantum BioPharma Ltd. is trading 10.1% down today following an FDA clinical hold on its Lucid-MS application
Quantum BioPharma Ltd. is trading at $4.72 (-10.10%) following an FDA clinical hold on its Lucid-MS IND application, which has significantly weighed on...